Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Radalbuvir

Generic Name: Radalbuvir

Drug Type: Small Molecule

Chemical Formula: C_₃₀H_₄₁NO_₆S

CAS Number: 1314795-11-3

Unique Ingredient Identifier: 273K4V0SPC

Overview

Radalbuvir has been used in trials studying the treatment of Chronic Hepatitis C, Chronic HCV Infection, and Chronic Hepatitis C Infection.

Background

Radalbuvir has been used in trials studying the treatment of Chronic Hepatitis C, Chronic HCV Infection, and Chronic Hepatitis C Infection.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

Phase 2

Completed

Posted: 2013/11/14

Sponsor:Gilead Sciences

ID:NCT01984294

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Phase 2

Completed

Posted: 2013/04/09

Sponsor:Gilead Sciences

ID:NCT01826981

Combination Therapy for Chronic Hepatitis C Infection

Phase 2

Completed

Posted: 2013/03/06

Sponsor:National Institute o...

ID:NCT01805882

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Phase 2

Completed

Posted: 2010/12/15

Sponsor:Gilead Sciences

ID:NCT01260350

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy